Adaze Bijou Enogieru

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum

Top Venues

Metabolic brain disease

Oxidative medicine and cellular longevity

Cerebellum (London, England)

Neurotoxicity research

This page only lists publications with an associated author ORCID identifier.

Publications

Adaze Bijou Enogieru, William Haylett, Donavon Hiss, Okobi Ekpo
Inhibition of γH2AX, COX-2 and regulation of antioxidant enzymes in MPP+-exposed SH-SY5Y cells pre-treated with rutin. Metabolic brain disease 36 (7) (2021)
Adaze Bijou Enogieru, Oghenakhogie Iroboudu Momodu
The Developing Cerebellum as a Target for Toxic Substances: Protective Role of Antioxidants. Cerebellum (London, England) 20 (4) (2021)
Adaze Bijou Enogieru, William Haylett, Donavon Charles Hiss, Okobi Eko Ekpo
Regulation of AKT/AMPK signaling, autophagy and mitigation of apoptosis in Rutin-pretreated SH-SY5Y cells exposed to MPP. Metabolic brain disease 36 (2) (2020)
Adaze Bijou Enogieru, William Lloyd Haylett, Hayley Christy Miller, Francois Hendrikus van der Westhuizen, Donavon Charles Hiss, Okobi Eko Ekpo
Attenuation of Endoplasmic Reticulum Stress, Impaired Calcium Homeostasis, and Altered Bioenergetic Functions in MPP+-Exposed SH-SY5Y Cells Pretreated with Rutin. Neurotoxicity research 36 (4) (2019)
Adaze Bijou Enogieru, Sylvester Ifeanyi Omoruyi, Donavon Charles Hiss, Okobi Eko Ekpo
GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson's Disease: A Mini Review. Advances in pharmacological sciences 2019 (2019)
Adaze Bijou Enogieru, William Haylett, Donavon Charles Hiss, Soraya Bardien, Okobi Eko Ekpo
Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders. Oxidative medicine and cellular longevity 2018 (2018)